Kulwinder Kaur

Kulwinder Kaur is a Lecturer in the School of Pharmacy and Biomolecular Sciences at the Royal College of Surgeons in Ireland (RCSI). Her academic journey includes a PhD from Guru Nanak Dev University (2012–2017) and postdoctoral roles at RCSI (2020–2023) and the Indian Institute of Technology Delhi (2017–2019). She specializes in bioengineering, biomaterials, and tissue engineering, with a focus on regenerative medicine and cancer therapy. Her research addresses bone regeneration, injectable hydrogels, and 3D disease models.

Research Interests: Her work spans

• Design of biomaterials for bone repair (e.g., chitosan/collagen hydrogels, silk fibroin composites)
• 3D bioengineered models for breast cancer and microbiota-gut-brain axis studies
• Nano-engineered hydrogels for minimally invasive treatments
• Gamma ray shielding materials for biomedical applications

Grants & Projects:

• "NanoDOT: Nano-Engineered Biomaterial Delivery System with Controlled Strontium Release" (Science Foundation Ireland, 2023–2027)
• "Injectable Chitosan/Collagen Hydrogels for Bone Repair" (European Research Council, 2022–2023)
• "Hydroxyapatite Bioceramics" (Department of Science & Technology, India, 2014–2017)

Labs & Collaborations: Her research integrates interdisciplinary teams focusing on biomaterials, regenerative medicine, and cancer biology. She collaborates with institutions like IIT Delhi and contributes to RCSI’s Biomaterials & Pharmaceuticals Sciences cluster.